Procter & Gamble Company (The) (NYSE:PG) Stock Rated “Moderate Buy” by Wall Street Analysts

Shares of Procter & Gamble Company (The) (NYSE:PG) have received an average recommendation of “Moderate Buy” from the twenty-four analysts that are currently covering the firm, MarketBeat.com reports. Ten research analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $162.20.

Several research firms have recently commented on PG. HSBC reissued a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. TD Cowen reissued a “hold” rating and issued a $150.00 price target on shares of Procter & Gamble in a report on Wednesday, September 30th. Barclays raised their price target on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Sanford C. Bernstein reiterated a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Finally, Citigroup raised their price objective on Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a report on Friday, October 9th.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $159.25 on Wednesday. Procter & Gamble has a 52 week low of $137.62 and a 52 week high of $167.25. The stock’s 50-day simple moving average is $146.88 and its 200-day simple moving average is $146.53. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $369.89 billion, a price-to-earnings ratio of 24.06, a PEG ratio of 3.96 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, analysts expect that Procter & Gamble will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio (DPR) is 65.71%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 359 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at approximately $184,600.04. The trade was a 22.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of the stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the transaction, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at $9,536,920.12. The trade was a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock worth $2,189,970 in the last ninety days. Company insiders own 0.23% of the company’s stock.

Institutional Trading of Procter & Gamble

Institutional investors have recently made changes to their positions in the company. BlackRock Inc. bought a new stake in shares of Procter & Gamble during the second quarter valued at approximately $27,862,105,000. Bank of America Corp DE bought a new position in Procter & Gamble in the 2nd quarter worth approximately $3,850,628,000. Bank of New York Mellon Corp bought a new position in Procter & Gamble in the 2nd quarter worth approximately $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Procter & Gamble during the 2nd quarter worth $1,480,650,000. Finally, Auto Owners Insurance Co lifted its holdings in Procter & Gamble by 14,231.0% during the 4th quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company’s stock worth $508,700,000 after buying an additional 3,524,876 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Improving U.S. sales outlook: UBS maintained its Buy rating and $172 price target, saying better U.S. sales momentum could help P&G outperform expectations when it reports before the market opens on October 22. Procter & Gamble’s improving US sales trends set up a favorable first-quarter report, UBS says
• Positive Sentiment: Defensive dividend appeal: Recent investor-focused coverage highlighted P&G’s 70-year record of dividend increases. That long history, combined with demand for everyday household products, may support the stock as investors seek stable income and less exposure to technology-sector volatility. Procter & Gamble Has Raised Its Dividend for 70 Years
• Neutral Sentiment: Upcoming earnings are the key catalyst: Analysts expect modest revenue growth for fiscal first-quarter 2027, while the company’s latest reported quarter showed revenue growth of 1.5% year over year and earnings that narrowly exceeded consensus. Investors will focus on organic sales, pricing, volumes and updated full-year guidance. Procter & Gamble Set to Release Earnings
• Negative Sentiment: Profit risks remain: Earnings previews warn that rising costs could pressure margins and cause quarterly earnings to decline, reducing the likelihood of a significant earnings beat. P&G’s valuation—about 24 times earnings based on the supplied data—also leaves less room for disappointment. Procter & Gamble Pre-Q1 Earnings
• Negative Sentiment: Some institutional selling: ETFs were reported as net sellers of PG, a modest near-term technical headwind, though this flow does not necessarily signal a change in the company’s long-term fundamentals. ETFs Are Net Sellers of Procter & Gamble

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.